[Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection].
Moreno García
M
M
Fernández González
F
F
Fernández Rodríguez
E
E
Portús de Marco
M V
MV
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000212:Acyclovir / Q000009:adverse effects; D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D002442:Ceftazidime / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy*; D011739:Pyrimethamine / Q000009:adverse effects; D013411:Sulfadiazine / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects
D000890:Anti-Infective Agents; D000998:Antiviral Agents; D002511:Cephalosporins; D013411:Sulfadiazine; D016179:Granulocyte Colony-Stimulating Factor; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002442:Ceftazidime; D000212:Acyclovir; D011739:Pyrimethamine
Factor estimulante de colonias de granulocitos en el tratamiento de la neutropenia asociada a la infección por VIH.